Recap: Strata Skin Sciences Q4 Earnings
Portfolio Pulse from Benzinga Insights
Strata Skin Sciences (NASDAQ:SSKN) reported Q4 earnings with an EPS of $-0.04, missing estimates by -100.0% and a revenue decrease of $1.91 million from the previous year. Despite beating EPS estimates last quarter, this marks a significant downturn.
March 27, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Strata Skin Sciences reported a significant miss in Q4 earnings with an EPS of $-0.04, underperforming estimates by 100%, and a notable decrease in revenue.
The significant miss in both EPS and revenue compared to estimates and the previous year's performance is likely to negatively impact investor sentiment and the stock price in the short term. Historical data shows that past earnings performance, especially beats, have led to stock price increases, suggesting that misses, particularly of this magnitude, could lead to declines.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100